YAP1 and gastric cancer: More importantly, our study investigated the prognostic potential of YAP1/SLC35B4 axis expression in survival of patients with GC, supporting the prognostic value of YAP1 and SLC35B4 expression, which allows clinicians to potentially identify candidate patients for appropriate treatment to improve therapeutic outcomes.